Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Ovid Therapeutics (OVID) Shares Outstanding (2020 - 2022)

Historic Shares Outstanding for Ovid Therapeutics (OVID) over the last 3 years, with Q3 2022 value amounting to $70.5 million.

  • Ovid Therapeutics' Shares Outstanding rose 360.23% to $70.5 million in Q3 2022 from the same period last year, while for Sep 2022 it was $70.5 million, marking a year-over-year increase of 360.23%. This contributed to the annual value of $70.4 million for FY2021, which is 703.0% up from last year.
  • Latest data reveals that Ovid Therapeutics reported Shares Outstanding of $70.5 million as of Q3 2022, which was up 360.23% from $70.4 million recorded in Q2 2022.
  • In the past 5 years, Ovid Therapeutics' Shares Outstanding ranged from a high of $70.5 million in Q3 2022 and a low of $54.8 million during Q1 2020
  • Over the past 3 years, Ovid Therapeutics' median Shares Outstanding value was $67.8 million (recorded in 2021), while the average stood at $66.0 million.
  • Per our database at Business Quant, Ovid Therapeutics' Shares Outstanding soared by 2380.42% in 2021 and then soared by 360.23% in 2022.
  • Quarter analysis of 3 years shows Ovid Therapeutics' Shares Outstanding stood at $65.7 million in 2020, then increased by 7.03% to $70.4 million in 2021, then increased by 0.14% to $70.5 million in 2022.
  • Its last three reported values are $70.5 million in Q3 2022, $70.4 million for Q2 2022, and $70.4 million during Q1 2022.